Literature DB >> 6491732

Outcome in 60 consecutive patients treated with early aneurysm operation and intravenous nimodipine.

B Ljunggren, L Brandt, H Säveland, P E Nilsson, S Cronqvist, K E Andersson, E Vinge.   

Abstract

Sixty consecutive patients with a ruptured supratentorial aneurysm underwent operation during the acute stage, 56 of them within 72 hours after the first bleed, one on the 4th day, and three on the 5th day. Six patients were classified preoperatively in Hunt and Hess neurological Grade I, 39 in Grade II, 11 in Grade III, and four in Grade IV or V. Nine patients had severe intracerebral hematomas, and one patient had a subdural hematoma. After the aneurysm was clipped, nimodipine was applied to the exposed arterial segments in a 2.5 X 10(-5)M solution for 10 minutes. Subsequently, all patients received a continuous intravenous nimodipine infusion (2 mg/hr) for 7 to 12 days, followed by oral treatment (270 mg/day). Forty-six patients (77%) made a good neurological recovery; the morbidity rate was 22%, and mortality rate 1.5%. Of the 45 patients in good condition (Grades I to II) preoperatively, 38 (84%) made a good neurological recovery. Two patients (3% of the total series) developed a typical picture of cerebral ischemic dysfunction of delayed onset with subsequent fixed neurological deficits. The results favor the opinion that early operative intervention is beneficial in patients in good condition rather than delaying surgery, and indicate that nimodipine provides an additional anti-ischemic effect. The appearance and severity of late angiographic vasospasm did not seem to be affected by nimodipine.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6491732     DOI: 10.3171/jns.1984.61.5.0864

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  41 in total

1.  Changes in the levels of neuropeptide Y-LI in the external jugular vein in connection with vasoconstriction following subarachnoid haemorrhage in man. Involvement of sympathetic neuropeptide Y in cerebral vasospasm.

Authors:  R Juul; L Edvinsson; T A Fredriksen; R Ekman; A O Brubakk; S E Gisvold
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

Review 2.  Aneurysmal subarachnoid hemorrhage: prevention of delayed ischemic dysfunction with intravenous nimodipine.

Authors:  B Ljunggren; L Brandt; H Säveland; B Romner; T Ryman; K E Andersson
Journal:  Neurosurg Rev       Date:  1987       Impact factor: 3.042

3.  The effect of nimodipine on autoregulation of cerebral blood flow after subarachnoid haemorrhage in rat.

Authors:  J Hauerberg; G Rasmussen; M Juhler; F Gjerris
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

4.  A Systematic Review of Cognitive Outcomes in Angiographically Negative Subarachnoid Haemorrhage.

Authors:  Tom Burke; Stephanie Hughes; Alan Carr; Mohsen Javadpour; Niall Pender
Journal:  Neuropsychol Rev       Date:  2018-10-23       Impact factor: 7.444

5.  Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine.

Authors:  J Philippon; R Grob; F Dagreou; M Guggiari; M Rivierez; P Viars
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

Review 6.  Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease.

Authors:  M S Langley; E M Sorkin
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

7.  Pharmacokinetics of nimodipine in patients with aneurysmal subarachnoid haemorrhage.

Authors:  E Vinge; K E Andersson; L Brandt; B Ljunggren; L G Nilsson; S Rosendal-Helgesen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  The role of ventricular and cisternal drainage in the early operation for ruptured intracranial aneurysms.

Authors:  S Sakaki; S Ohta; H Kuwabara; M Shiraishi
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

9.  Oral nimodipine reduces prostaglandin and thromboxane production by arteries chronically exposed to a periarterial haematoma and the antifibrinolytic agent tranexamic acid.

Authors:  J D Pickard; V Walker; J Vile; S Perry; P J Smythe; R Hunt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-06       Impact factor: 10.154

10.  CT-findings in haemorrhages from aneurysms of the anterior communicating artery: correlation with angiography and clinical course.

Authors:  P Stoeter; H J Reulen; U Groeger
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.